Is sunitinib-induced hypothyroidism a predictive clinical marker for better response in metastatic renal cell carcinoma patients?

dc.contributor.authorOzkan, Metin
dc.contributor.authorBozkurt, Oktay
dc.contributor.authorHacibekiroglu, Ilhan
dc.contributor.authorKaplan, Muhammet Ali
dc.contributor.authorDuzkopru, Yakup
dc.contributor.authorUysal, Mukremin
dc.contributor.authorKaraca, Halit
dc.date.accessioned2024-04-24T17:15:00Z
dc.date.available2024-04-24T17:15:00Z
dc.date.issued2015
dc.departmentDicle Üniversitesien_US
dc.descriptionAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer -- MAY 29-JUN 02, 2015 -- Chicago, ILen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipAmer Soc Clin Oncolen_US
dc.identifier.doi10.1200/jco.2015.33.15_suppl.e15624
dc.identifier.issn0732-183X
dc.identifier.issn1527-7755
dc.identifier.issue15en_US
dc.identifier.urihttps://doi.org/10.1200/jco.2015.33.15_suppl.e15624
dc.identifier.urihttps://hdl.handle.net/11468/18295
dc.identifier.volume33en_US
dc.identifier.wosWOS:000358036903163
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoenen_US
dc.publisherAmer Soc Clinical Oncologyen_US
dc.relation.ispartofJournal of Clinical Oncology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keyword]en_US
dc.titleIs sunitinib-induced hypothyroidism a predictive clinical marker for better response in metastatic renal cell carcinoma patients?en_US
dc.titleIs sunitinib-induced hypothyroidism a predictive clinical marker for better response in metastatic renal cell carcinoma patients?
dc.typeConference Objecten_US

Dosyalar